ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Program

Metronidazole

Also written as “metronidazole 1% gel”, “Metronidazole Tablet” and “metronidazole”.

Its studies are mostly in Intraabdominal Infections · Vaginosis, Bacterial · Rosacea · Appendicitis · Skin Manifestations, led by 11 companies.

Drug pageMetronidazole: every studyMany companies study it; this page follows only the 27 they lead. All 226 studies, academic ones too, with its approvals and label.
Furthest: phase 4, since Sep 12, 200527 company-led studies, 1 open or running

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Pfizer80 open or runningphase 4since Sep 12, 2005Sep 12, 2005none ahead
Galderma Groupits history only40 open or runningphase 4since Feb 16, 2007Feb 16, 2007none ahead
S.L.A. Pharmaits history only40 open or runningphase 3since Jul 30, 2007Jul 30, 2007none ahead
Curatek Pharmaceuticalsits history only20 open or runningphase 3since Dec 1, 2014Dec 1, 2014none ahead
Par Healthits history only20 open or runningphase 1since Jun 16, 2011Jun 16, 2011none ahead
Teva Pharmaceutical Industriesits history only20 open or runningphase 2since Nov 24, 2009Nov 24, 2009none ahead
Appili Therapeuticsits history only10 open or runningphase 1since Nov 6, 2017Nov 6, 2017none ahead
bioRASIits history only10 open or runningphase 3since Mar 12, 2015Mar 12, 2015none ahead
Dr. Reddy's Laboratoriesits history only10 open or runningphase 2since Mar 19, 2012Mar 19, 2012none ahead
Insud Pharmaits history only10 open or runningphase 4since Mar 4, 2015Mar 4, 2015none ahead

Also a collaborator on its studies: Allergan Sales, AbbVie, Algorithme Pharma and PriCara, Unit of Ortho-McNeil.

How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.

History and studies of Pfizer only; the figures above count every company.

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Sep 12, 2005First studies: 2 phase 4 studies in AppendicitisFirst studyNCT00195351, NCT00230971
  2. Jul 20, 2011Phase 1 study in InfectionsNCT01407016 · 6 enrolled · Japan
  3. Oct 11, 2011Phase 3 study in Intraabdominal InfectionsNCT01473836 · 38 enrolled · Japan
  4. Dec 19, 2011Phase 3 study in Complicated Intra-Abdominal InfectionNCT01499290 · 493 enrolled · United States, Argentina, Bulgaria and more
  5. Feb 9, 2012Phase 1 study in HealthyNCT01534247 · 28 enrolled · United States
  6. Nov 5, 2012Phase 3 study in Complicated Intra-abdominal InfectionNCT01726023 · 486 enrolled · China, Korea, Republic of, Vietnam
  7. May 25, 2015Phase 2 study in Complicated Intra-abdominal InfectionsNCT02475733 · 83 enrolled · United States, Czechia, Greece and more

TargetBeta

A vaccine: it acts on a pathogen, not a human gene.

“DNA inhibitor; DNA inhibitor”ChEMBL 37, by rule

Studies

All 8 Pfizer leads, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT02475733Complicated Intra-abdominal Infections · United States, Czechia, Greece and more2CompletedJun 1, 201783
NCT01726023Complicated Intra-abdominal Infection · China, Korea, Republic of, Vietnam3CompletedMar 2015486
NCT01534247Healthy · United States1CompletedJul 201228
NCT01499290Complicated Intra-Abdominal Infection · United States, Argentina, Bulgaria and more3CompletedApr 2014493
NCT01473836Intraabdominal Infections · Japan3CompletedOct 201238
NCT01407016Infections · Japan1CompletedSep 20116
NCT00230971Appendicitis · Australia, China, Denmark and more4CompletedSep 2008473
NCT00195351Appendicitis · United States, Argentina, Brazil and more4CompletedFeb 2008467

How it is read

Names in the registry

  • “Metronidazole”, 20 entries
  • “metronidazole 1% gel”, 2 entries
  • “Metronidazole Tablet”, 2 entries
  • “metronidazole”, 2 entries
  • “Likmez® (metronidazole) Oral Suspension”, 1 entry

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.